These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 27735902)

  • 1. [Antiamnesic effects divaza and its component model β-amyloid amnesia].
    Ganinа KK; Duginа YL; Zhavbert ES; Ertuzun IA; Epstein OI; Mukhin VN; Abdurasulova IN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(9):69-74. PubMed ID: 27735902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiamnestic effects of antibodies to glutamate in experimental Alzheimer's disease.
    Gorbatov VY; Trekova NA; Fomina VG; Davydova TV
    Bull Exp Biol Med; 2010 Dec; 150(1):23-5. PubMed ID: 21161042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ropren(®) is a polyprenol preparation from coniferous plants that ameliorates cognitive deficiency in a rat model of beta-amyloid peptide-(25-35)-induced amnesia.
    Fedotova J; Soultanov V; Nikitina T; Roschin V; Ordayn N
    Phytomedicine; 2012 Mar; 19(5):451-6. PubMed ID: 22305275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dehydroevodiamine attenuates beta-amyloid peptide-induced amnesia in mice.
    Wang HH; Chou CJ; Liao JF; Chen CF
    Eur J Pharmacol; 2001 Feb; 413(2-3):221-5. PubMed ID: 11226396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nootropic and antiamnestic effects of tenoten (pediatric formulation) in immature rat pups.
    Voronina TA; Molodavkin GM; Borodavkina MV; Kheyfets IA; Dugina YL; Sergeeva SA
    Bull Exp Biol Med; 2009 Sep; 148(3):524-6. PubMed ID: 20396730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynorphin A-(1-13) attenuates basal forebrain-lesion-induced amnesia in rats.
    Ukai M; Kobayashi T; Kameyama T
    Brain Res; 1993 Oct; 625(2):355-6. PubMed ID: 7903901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive-enhancing activities of the polyprenol preparation Ropren® in gonadectomized β-amyloid (25-35) rat model of Alzheimer's disease.
    Fedotova J; Soultanov V; Nikitina T; Roschin V; Ordyan N; Hritcu L
    Physiol Behav; 2016 Apr; 157():55-62. PubMed ID: 26821186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiamnesic activity of nerve growth factor adsorbed on poly(butyl) cyanoacrylate nanoparticles coated with polysorbate-80].
    Basel AA; Petrov VE; Trofimov SS; Voronina TA; Aliautdin RN
    Eksp Klin Farmakol; 2005; 68(6):3-8. PubMed ID: 16405025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Use of Release-Active Antibody-Based Preparations for Vertigo Prevention in Adults.
    Barchukov VV; Zhavbert ES; Dugina YL; Epstein OI
    Bull Exp Biol Med; 2015 Nov; 160(1):61-3. PubMed ID: 26608378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice.
    Dall'Igna OP; Fett P; Gomes MW; Souza DO; Cunha RA; Lara DR
    Exp Neurol; 2007 Jan; 203(1):241-5. PubMed ID: 17007839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Farmacological effects of anti-S 100 in release-active form and mechanisms of their realization].
    Khakimova GR; Voronina TA; Dugina YL; Ertuzun IA; Epshtein OI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(4):100-113. PubMed ID: 27386593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive improvement of compound danshen in an Aβ25-35 peptide-induced rat model of Alzheimer's disease.
    Liu M; Guo H; Li C; Wang D; Wu J; Wang C; Xu J; Qin RA
    BMC Complement Altern Med; 2015 Oct; 15():382. PubMed ID: 26497584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memory deficits and increased emotionality induced by beta-amyloid (25-35) are correlated with the reduced acetylcholine release and altered phorbol dibutyrate binding in the hippocampus.
    Olariu A; Tran MH; Yamada K; Mizuno M; Hefco V; Nabeshima T
    J Neural Transm (Vienna); 2001; 108(8-9):1065-79. PubMed ID: 11716142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of baicalein on beta-amyloid peptide-(25-35)-induced amnesia in mice.
    Wang SY; Wang HH; Chi CW; Chen CF; Liao JF
    Eur J Pharmacol; 2004 Dec; 506(1):55-61. PubMed ID: 15588624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memory loss caused by beta-amyloid protein is rescued by a beta(3)-adrenoceptor agonist.
    Gibbs ME; Maksel D; Gibbs Z; Hou X; Summers RJ; Small DH
    Neurobiol Aging; 2010 Apr; 31(4):614-24. PubMed ID: 18632189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amnestic effects in mice of four synthetic peptides homologous to amyloid beta protein from patients with Alzheimer disease.
    Flood JF; Morley JE; Roberts E
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3363-6. PubMed ID: 2014256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Jen-San-Yaung-Jung-Tang on scopolamine-induced amnesia in rats.
    Lu MC
    Am J Chin Med; 1998; 26(2):117-25. PubMed ID: 9799963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative activity of memory-modulating neuropeptides before and after electric shock in white rats.
    Medvedev VI; Bakharev VD; Kaurov OA
    Neurosci Behav Physiol; 1985; 15(3):240-6. PubMed ID: 2863780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Perspectives of the novel drug divaza in the treatment of chronic cerebral ischemia].
    Tanaeva KK; Dugina IuL; Kachaeva EV; Epshteĭn OI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(9):100-4. PubMed ID: 25473662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ameliorating effects of luteolin on beta-amyloid-induced impairment of water maze performance and passive avoidance in rats.
    Tsai FS; Cheng HY; Hsieh MT; Wu CR; Lin YC; Peng WH
    Am J Chin Med; 2010; 38(2):279-91. PubMed ID: 20387225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.